Chengdu Shengnuo Biopharm Co.,Ltd.(\"Shengnuo\") is specialized in peptide research,manufacturing and sales in China. It was founded in Chengdu in March, 2004 by a team of experienced peptide chemists. There are10 US-DMFs(Semaglutide,linaclotide,Bivalirudin, Liraglutide, Eptifibatide, Icatibant,Octreotide,Teriparatide,Ganirelix and Ziconotide). \"Shengnuo\" had passed the inspection of US-FDA and Mexico FDA four times. \"Shengnuo\" has a few peptide API Chinese GMP certificates, such as Enfuvirtide, Levosimendan, Somatostatin, Octreotide, Thymosin alpha1, Carbetocin , Atosiban and Thymopenin. Exenatide,Tirzepeptide,Ganirelix,Degarelix,Cetrorelix,Teduglutide is under research. \
Shengnuo regestered in many countries for the API .and we are working on the formulation plant and hope can export in the future.
more >
Year of Establishment:
2003
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia
Other Competitive Advantages:
Patents and Copyrights: